(Q35967372)

11 August 2017

1 reference

title

Use of cytokines in infection (English)

1 reference

11 August 2017

Naoko Aoki

1

1 reference

11 August 2017

Zhou Xing

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Emerging Drugs

11 August 2017

1 reference

11 August 2017

9

1 reference

11 August 2017

2

1 reference

11 August 2017

223-236

1 reference

Consideration of cytokines as therapeutics agents or targets

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Recent developments in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Advance in treatment strategy and immune reconstruction against HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Immunotherapy for invasive fungal infections: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Allergy, parasites, and the hygiene hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

The two faces of IL-6 on Th1/Th2 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

A novel transcription factor, T-bet, directs Th1 lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

T helper subset development: roles of instruction, selection, and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Mycobacterium leprae and leprosy: a compendium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Interferon-gamma in the management of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Macrophages are a significant source of type 1 cytokines during mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

The role of interleukin-12 in human infectious diseases: only a faint signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Treatment of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

IL-12: the role of p40 versus p75

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

A unique role for IL-23 in promoting cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Anti-inflammatory cytokines and cytokine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Tumor necrosis factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Cytokine therapeutics for the treatment of sepsis: why has nothing worked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Expression cloning of new receptors used by simian and human immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Co-receptor antagonists as HIV-1 entry inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

HIV-1 coreceptor usage, transmission, and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Therapeutics targeting the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Novel generations of influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Candidate vaccines for immunotherapy in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

HIV and chemokines: implications for therapy and vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.2.223

21 January 2018

Identifiers

DOI

10.1517/14728214.9.2.223

1 reference

release_nejmb6g4pbfjtpnwo72r7e76fu

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nejmb6g4pbfjtpnwo72r7e76fu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference